Erbel Raimund, Möhlenkamp Stefan, Lehmann Nils, Schmermund Axel, Moebus Susanne, Stang Andreas, Grönemeyer Dietrich, Seibel Rainer, Mann Klaus, Volbracht Lothar, Dragano Nico, Siegrist Johannes, Jöckel Karl-Heinz
Clinic of Cardiology, West-German Heart Center, University Duisburg-Essen, Germany.
Atherosclerosis. 2008 Apr;197(2):662-72. doi: 10.1016/j.atherosclerosis.2007.02.031. Epub 2007 Mar 26.
An ongoing population-based cohort study was used to assess the prevalence of risk factors, signs of inflammation based on the degree of high sensitive C-reactive protein (hs-CRP) and subclinical atherosclerosis using electron beam computed tomography for detection of coronary artery calcification (CAC). We evaluated the sex related cardiovascular risk stratification based on quantification of subclinical atherosclerosis and inflammation.
The National Cholesterol Education Program in Adult Treatment Panel III (NCEP ATP III) suggests using CAC and hs-CRP in individuals at intermediate risk. The effect on risk stratification was not yet tested in the general population.
In the Heinz Nixdorf Recall study 4066 (93.2%) subjects without and 280 (6.8%) of 4345 subjects with coronary artery disease (CAD) (age 45-75 years) were screened in whom data for CAC, hs-CRP, and all risk factors for calculating the Framingham risk score (FRS) were available. This subset of participants was representative of the overall population. Age-adjusted prevalence rate ratios (RR) for prevalence of CAD in relation to risk factors were determined. Framingham risk score groups and NCEP ATP III-based risk categories were calculated. Alterations in risk classification were analyzed using three CAC and hs-CRP categories each: (1) CAC<100, 100-399 and > or =400 or >75th percentile, respectively, (2) hs-CRP< or =1, 1-3, >3mg/L, and (3) a combined CAC and hs-CRP score.
Highest RRs of CAD were found for high CAC versus low CAC in men (RR=18.2, 95% CI=10.6-31.3) and for the combined CAC+hs-CRP index in women (RR=11.0, 95% CI=5.1-23.6, both p<0.0001). For high versus low hs-CRP-values a significant RR was found for women only (RR=2.5, 95% CI=1.3-4.6, p<0.01). RRs for other risk factors like hyperlipidemia, HDL, smoking, BMI>30 kg/m(2) were much smaller showing sex differences as well. Thirty percent males and 71% females were classified as low NCEP ATP III risk, 38% and 20% as intermediate and 31% and 9% as high risk. Adding CAC and hs-CRP to NCEP ATP risk categories changed distribution of risk categories considerably with strong differences between sexes. This sex dependence in the magnitude of change in risk categories nearly vanished, when the combined index of CAC and hs-CRP was used.
NCEP ATP III risk categories are significantly and sex-dependently altered using CAC and hs-CRP. CAC is suggested to be of highest value in men; hs-CRP seems to be of complementary value only in women. Measuring atherosclerotic inflammation may improve sex-related risk prediction in a general population.
采用一项正在进行的基于人群的队列研究,评估危险因素的患病率、基于高敏C反应蛋白(hs-CRP)水平的炎症迹象以及使用电子束计算机断层扫描检测冠状动脉钙化(CAC)来评估亚临床动脉粥样硬化情况。我们基于亚临床动脉粥样硬化和炎症的量化评估了性别相关的心血管风险分层。
成人治疗组第三次国家胆固醇教育计划(NCEP ATP III)建议在中度风险个体中使用CAC和hs-CRP。其对风险分层的影响尚未在普通人群中进行测试。
在海因茨·尼克斯多夫召回研究中,对4345名年龄在45 - 75岁的受试者进行了筛查,其中4066名(93.2%)无冠状动脉疾病(CAD),280名(6.8%)患有CAD。这些受试者可获取CAC、hs-CRP以及计算弗雷明汉风险评分(FRS)所需的所有危险因素数据。这部分参与者代表了总体人群。确定了与危险因素相关的CAD患病率的年龄调整患病率比(RR)。计算了弗雷明汉风险评分组和基于NCEP ATP III的风险类别。使用三个CAC和hs-CRP类别分析风险分类的变化:(1)CAC分别<100、100 - 399和>或 = 400或>第75百分位数,(2)hs-CRP<或 = 1、1 - 3、>3mg/L,以及(3)一个综合的CAC和hs-CRP评分。
男性中高CAC与低CAC相比CAD的RR最高(RR = 18.2,95%CI = 10.6 - 31.3),女性中综合的CAC + hs-CRP指数对应的RR最高(RR = 11.0,95%CI = 5.1 - 23.6,两者p<0.0001)。仅在女性中,高hs-CRP值与低hs-CRP值相比有显著的RR(RR = 2.5,95%CI = 1.3 - 4.6,p<0.01)。其他危险因素如高脂血症、高密度脂蛋白、吸烟、BMI>30 kg/m²的RR要小得多,也显示出性别差异。30%的男性和71%的女性被归类为低NCEP ATP III风险,38%和20%为中度风险,31%和9%为高风险。将CAC和hs-CRP添加到NCEP ATP风险类别中,显著改变了风险类别的分布,且性别之间存在很大差异。当使用CAC和hs-CRP的综合指数时,这种风险类别变化幅度中的性别依赖性几乎消失。
使用CAC和hs-CRP可显著且性别依赖性地改变NCEP ATP III风险类别。建议CAC对男性价值最高;hs-CRP似乎仅对女性具有补充价值。测量动脉粥样硬化炎症可能改善普通人群中与性别相关的风险预测。